Financial reports
10-Q
2020 Q3
Quarterly report
18 Feb 20
NT 10-Q
Notice of late quarterly filing
14 Feb 20
10-Q
2020 Q2
Quarterly report
14 Nov 19
10-Q
2020 Q1
Quarterly report
14 Aug 19
10-K
2019 FY
Annual report
1 Jul 19
10-Q
2019 Q3
Quarterly report
13 Feb 19
10-Q
2019 Q2
Quarterly report
14 Nov 18
10-Q
2019 Q1
Quarterly report
14 Aug 18
10-K
2018 FY
Annual report
28 Jun 18
10-Q
2018 Q3
Quarterly report
14 Feb 18
Current reports
8-K
Applied BioSciences Announces Retirement of Convertible Note
23 Mar 20
8-K
Departure of Directors or Certain Officers
19 Mar 20
8-K
Applied BioSciences Reports Second Quarter Fiscal Year 2020 Financial Results and Outlines Corporate Strategy
15 Nov 19
8-K
Other Events
28 Oct 19
8-K
Applied BioSciences Appoints Michael Beaubaire, M.D. to its Board of Directors
7 Oct 19
8-K
Departure of Directors or Certain Officers
16 Sep 19
8-K
Entry into a Material Definitive Agreement
13 Sep 19
8-K
Applied BioSciences Reports First Quarter FY2020 Financial Results and Provides Corporate Update
15 Aug 19
8-K
Departure of Directors or Certain Officers
28 May 19
8-K
Departure of Directors or Certain Officers
19 Apr 19
Registration and prospectus
15-12G
Securities registration termination
1 May 20
RW
Registration withdrawal request
26 Dec 18
S-1
IPO registration
3 Dec 18
8-A12G
Registration of securities
2 Oct 15
S-1/A
IPO registration (amended)
14 Jan 15
S-1/A
IPO registration (amended)
18 Dec 14
S-1/A
IPO registration (amended)
12 Dec 14
S-1/A
IPO registration (amended)
12 Nov 14
S-1/A
IPO registration (amended)
16 Oct 14
S-1
IPO registration
16 Jul 14
Ownership